Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells

Oncogene volume 25, pages 622–632 (2006)Cite this article

Abstract

The p53 protein has been implicated in multiple cellular responses related to DNA damage. Alterations in any of these cellular responses could be related to increased genomic instability. Our previous study has shown that mutations in p53 lead to hypermutability to ionizing radiation. To investigate further how p53 is involved in regulating mutational processes, we used 8K cDNA microarrays to compare the patterns of gene expression among three closely related human cell lines with different p53 status including TK6 (wild-type p53), NH32 (p53-null), and WTK1 (mutant p53). Total RNA samples were collected at 1, 3, 6, 9, and 24 h after 10 Gy γ-irradiation. Template-based clustering analysis of the gene expression over the time course showed that 464 genes are either up or downregulated by at least twofold following radiation treatment. In addition, cluster analyses of gene expression profiles among these three cell lines revealed distinct patterns. In TK6, 165 genes were upregulated, while 36 genes were downregulated. In contrast, in WTK1 75 genes were upregulated and 12 genes were downregulated. In NH32, only 54 genes were upregulated. Furthermore, we found several genes associated with DNA repair namely p53R2, DDB2, XPC, PCNA, BTG2, and MSH2 that were highly induced in TK6 compared to WTK1 and NH32. p53R2, which is regulated by the tumor suppressor p53, is a small subunit of ribonucleotide reductase. To determine whether it is involved in radiation-induced mutagenesis, p53R2 protein was inhibited by siRNA in TK6 cells and followed by 2 Gy radiation. The background mutation frequencies at the TK locus of siRNA-transfected TK6 cells were about three times higher than those seen in TK6 cells. The mutation frequencies of siRNA-transfected TK6 cells after 2 Gy radiation were significantly higher than the irradiated TK6 cells without p53R2 knock down. These results indicate that p53R2 was induced by p53 protein and is involved in protecting against radiation-induced mutagenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Amundson SA, Do KT, Shahab S, Bittner M, Meltzer P, Trent J et al. (2000). Radiat Res 154: 342–346.

  • Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V, Koller BH . (2001). Cancer Res 61: 6577–6582.

  • Barcellos CK, Schetinger MR, Battastini AM, Silva LB, Dias RD, Sarkis JJ . (1994). Braz J Med Biol Res 27: 1111–1115.

  • Benjamin MB, Potter H, Yandell DW, Little JB . (1991). Proc Natl Acad Sci USA 88: 6652–6656.

  • Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY et al. (2002). Cancer Res 62: 1213–1221.

  • Chuang YY, Chen Q, Brown JP, Sedivy JM, Liber HL . (1999). Cancer Res 59: 3073–3076.

  • Chuang YY, Chen Y, Chandramouli GVR, Cook JA, Coffin D et al. (2002). Cancer Res 62: 6246–6254.

  • Coelho D, Fischer B, Holl V, Jung GM, Dufour P, Bergerat JP et al. (2002). Radiat Res 157: 446–452.

  • Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . (2001). Nature 411: 494–498.

  • Elliott B, Jasin M . (2001). Mol Cell Biol 21: 2671–2682.

  • Evans E, Sugawara N, Haber JE, Alani E . (2000). Mol Cell 5: 789–799.

  • Ewan KB, Henshall-Powell RL, Ravani SA, Pajares MJ, Arteaga C, Warters R et al. (2002). Cancer Res 62: 5627–5631.

  • Fitch ME, Cross IV, Turner SJ, Adimoolam S, Lin CX, Williams KG et al. (2003). DNA Repair (Amsterdam) 2: 819–826.

  • Furth EE, Thilly WG, Penman BW, Liber HL, Rand WM . (1981). Anal Biochem 110: 1–8.

  • Geffrotin C, Tricaud Y, Crechet F, Castelli M, Lefaix JL, Vaiman M . (1998). Radiat Res 149: 472–481.

  • Gong B, Almasan A . (2000). Cancer Res 60: 5754–5760.

  • Guittet O, Hakansson P, Voevodskaya N, Fridd S, Graslund A, Arakawa H et al. (2001). J Biol Chem 276: 40647–40651.

  • Holbrook NJ, Liu Y, Fornace Jr AJ . (1996). EXS 77: 273–288.

  • Kawai H, Yamada Y, Tatsuka M, Niwa O, Yamamoto K, Suzuki F . (1999). Cancer Res 59: 6038–6041.

  • Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H . (2003). Nat Genet 34: 440–445.

  • Krikos A, Laherty CD, Dixit VM . (1992). J Biol Chem 267: 17971–17976.

  • Lakin ND, Jackson SP . (1999). Oncogene 18: 7644–7655.

  • Lin ZP, Belcourt MF, Cory JG, Sartorelli AC . (2004). J Biol Chem 279: 27030–27038.

  • Little JB, Nagasawa H, Keng PC, Yu Y, Li CY . (1995). J Biol Chem 270: 11033–11036.

  • Lozano G, Elledge SJ . (2000). Nature 404: 24–25.

  • Nakano K, Balint E, Ashcroft M, Vousden KH . (2000). Oncogene 19: 4283–4289.

  • Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS . (2002). Cancer Res 62: 6400–6404.

  • Russo SM, Tepper JE, Baldwin Jr AS, Liu R, Adams J, Elliott P et al. (2001). Int J Radiat Oncol Biol Phys 50: 183–193.

  • Schena M, Shalon D, Davis RW, Brown PO . (1995). Science 270: 467–470.

  • Skopek TR, Liber HL, Penman BW, Thilly WG . (1978). Biochem Biophys Res Commun 84: 411–416.

  • Smith ML, Fornace Jr AJ . (1996). Mutat Res 340: 109–124.

  • Sugasawa K, Okamoto T, Shimizu Y, Masutani C, Iwai S, Hanaoka F . (2001). Genes Dev 15: 507–521.

  • Tan T, Chu G . (2002). Mol Cell Biol 22: 3247–3254.

  • Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K et al. (2000). Nature 404: 42–49.

  • Teramoto T, Kiss A, Thorgeirsson SS . (1998). Biochem Biophys Res Commun 251: 56–60.

  • Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, Collins T . (1999). J Biol Chem 274: 1879–1882.

  • Wakefield LM, Roberts AB . (2002). Curr Opin Genet Dev 12: 22–29.

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS . (1998). Science 281: 1680–1683.

  • Webster GA, Perkins ND . (1999). Mol Cell Biol 19: 3485–3495.

  • Won KA, Schumacher RJ, Farr GW, Horwich AL, Reed SI . (1998). Mol Cell Biol 18: 7584–7589.

  • Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT et al. (1995). Cancer Res 55: 12–15.

  • Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y et al. (2003). Cancer Res 63: 980–986.

  • Yamaguchi T, Matsuda K, Sagiya Y, Iwadate M, Fujino MA, Nakamura Y et al. (2001). Cancer Res 61: 8256–8262.

  • Yang CR, Wilson-Van Patten C, Planchon SM, Wuerzberger-Davis SM, Davis TW, Cuthill S et al. (2000). FASEB J 14: 379–390.

  • Yang Q, Zhang R, Wang XW, Linke SP, Sengupta S, Hickson ID et al. (2004). Oncogene 23: 3749–3756.

  • Yu Y, Li CY, Little JB . (1997). Oncogene 14: 1661–1667.

  • Yu Y, Little JB . (1998). Cancer Res 58: 4277–4281.

  • Zhao W, Spitz DR, Oberley LW, Robbins ME . (2001). Cancer Res 61: 5537–5543.

Download references

Author information

Authors and Affiliations

  1. Radiation Biology and Oncology Branches, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    M-H Tsai, X Chen, H Yan, S Zhao, C N Coleman, J B Mitchell & E Y Chuang

  2. Advanced Technology Center, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    G V R Chandramouli

  3. Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA

    Y Chen

  4. Radiation Oncology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA

    P Keng

  5. Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA

    H L Liber

  6. Department of Electrical Engineering, National Taiwan University, Taipei, Taiwan

    E Y Chuang

Authors
  1. M-H Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G V R Chandramouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Keng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H L Liber
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C N Coleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J B Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E Y Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Y Chuang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsai, MH., Chen, X., Chandramouli, G. et al. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells. Oncogene 25, 622–632 (2006). https://doi.org/10.1038/sj.onc.1209082

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209082

Keywords

This article is cited by

Search

Advanced search

Quick links